Carmen D. Schweighofer

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

Kirsten Fischer, Paula Cramer, Raymonde Busch et al. · Journal of Clinical Oncology · 2011 · 372 citations

Medicine, Oncology, Pharmacotherapy +14

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

Barbara Eichhorst, Raymonde Busch, Stephan Stilgenbauer et al. · Blood · 2009 · 333 citations

Medicine, Oncology, Pharmacotherapy +7

Consolidation with alemtuzumab improves progression‐free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long‐term follow‐up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

Carmen D. Schweighofer, Matthias Ritgen, Barbara Eichhorst et al. · British Journal of Haematology · 2008 · 101 citations

Medicine, Immunology, Oncology +15

Bendamustine in Combination with Rituximab (BR) for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL): A Multicentre Phase II Trial of the German CLL Study Group (GCLLSG)

Kirsten Fischer, Stephan Stilgenbauer, Carmen D. Schweighofer et al. · Blood · 2008 · 99 citations

Medicine, Oncology, Pharmacotherapy +12

Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors

Clemens‐Martin Wendtner, David M. Kofler, Christian Kurzeder et al. · Blood · 2002 · 79 citations

Life Sciences, Biotechnology, Molecular Biology +17